Austin, United States
Revealix is an innovative company specializing in the integration of AI and healthcare, focusing on preventing diabetic foot complications. Founded in 2014 and headquartered in the United States, Revealix positions itself in the critical prevention phase of diabetic healthcare. Their platform serves as a clinical decision support tool, enabling healthcare providers to detect and address diabetic foot health risks before they escalate into severe complications.
Their mission, encapsulated by the slogan "Risk revealed. Wounds intercepted.", emphasizes the importance of early detection, claiming that 75% of diabetic foot ulcers are preventable with proactive intervention. By offering a streamlined 3-minute workflow for clinicians, Revealix aims to significantly reduce the risks of foot ulcers, admissions, and amputations among the diabetic population.
In September 2019, Revealix secured a seed investment of $120.00K from notable investors such as Techstars and UnitedHealthcare, underscoring the market's confidence in their unique value proposition and their strong potential for growth.
